Danaher (NYSE:DHR) (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs. Danaher’s operating companies deliver equipment and consumables used in sample preparation, molecular and cellular analysis, clinical diagnostics, water quality testing and other applied testing workflows, often combining hardware with software and service offerings to provide end-to-end solutions for customers.
Founded in 1969, Danaher has grown through organic development and acquisitions to build a diversified group of technology-oriented businesses. The company is headquartered in Washington, D.C., and serves customers worldwide across North America, Europe, Asia and other global markets. Danaher is also known for its emphasis on continuous improvement and operational excellence through the Danaher Business System, and it is governed by a board of directors and an executive leadership team. The company is publicly traded on the New York Stock Exchange under the ticker DHR.
